HLS Therapeutics (HLS) News Today C$3.18 -0.07 (-2.15%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Stifel Canada Forecasts Weaker Earnings for HLS TherapeuticsHLS Therapeutics Inc. (TSE:HLS - Free Report) - Equities research analysts at Stifel Canada decreased their FY2024 EPS estimates for HLS Therapeutics in a research report issued on Tuesday, November 12th. Stifel Canada analyst J. Keywood now expects that the company will earn ($0.88) per share foNovember 15 at 6:32 AM | marketbeat.comOptimistic Buy Rating for HLS Therapeutics Despite Revenue ChallengesNovember 10, 2024 | markets.businessinsider.comHLS Therapeutics Third Quarter 2024 Earnings: Misses ExpectationsNovember 8, 2024 | finance.yahoo.comHLS Therapeutics Inc (HLTRF) Q3 2024 Earnings Call Highlights: Strategic Debt Reduction and ...November 8, 2024 | finance.yahoo.comHLS Therapeutics Inc (TSX:HLS) Q3 2024: Everything You Need To Know Ahead Of EarningsNovember 6, 2024 | finance.yahoo.comHLS Therapeutics (HLS) Set to Announce Earnings on ThursdayHLS Therapeutics (TSE:HLS) will be releasing earnings before the market opens on Thursday, November 7, Zacks reports.October 31, 2024 | marketbeat.comHLS Therapeutics (TSE:HLS) Hits New 1-Year Low - What's Next?HLS Therapeutics (TSE:HLS) Reaches New 1-Year Low - Here's WhyOctober 25, 2024 | marketbeat.comHLS Therapeutics Inc. (TSE:HLS) Shares Could Be 38% Below Their Intrinsic Value EstimateOctober 17, 2024 | finance.yahoo.comDantech Announces Participation as a Silver Sponsor at BioFuture 2024 in New York CityOctober 14, 2024 | finance.yahoo.comHLS Therapeutics (TSE:HLS) Stock Price Down 4.3% - Time to Sell?HLS Therapeutics (TSE:HLS) Trading Down 4.3% - Here's What HappenedOctober 10, 2024 | marketbeat.comHLS Therapeutics Inc (HLTRF) Q2 2024 Earnings Call Highlights: Strategic Growth Amid Revenue ...October 9, 2024 | finance.yahoo.comHLS Therapeutics (TSE:HLS) Trading Down 0.6%HLS Therapeutics (TSE:HLS) Shares Down 0.6%September 18, 2024 | marketbeat.comHLS Therapeutics to Present at H.C. Wainwright's 26th Annual Global Investment ConferenceAugust 28, 2024 | finance.yahoo.comHLS Therapeutics (TSE:HLS) Reaches New 12-Month Low at $3.00HLS Therapeutics (TSE:HLS) Hits New 1-Year Low at $3.00August 26, 2024 | marketbeat.comHLS Therapeutics Inc. (74D.F)August 23, 2024 | finance.yahoo.comHLS Therapeutics Inc. (TSE:HLS) to Post Q3 2024 Earnings of ($0.19) Per Share, Stifel Canada ForecastsHLS Therapeutics Inc. (TSE:HLS - Free Report) - Research analysts at Stifel Canada boosted their Q3 2024 EPS estimates for HLS Therapeutics in a research note issued to investors on Monday, August 12th. Stifel Canada analyst J. Keywood now expects that the company will post earnings of ($0.19) peAugust 15, 2024 | marketbeat.comHLS Therapeutics (TSE:HLS) Given New C$3.25 Price Target at Stifel NicolausStifel Nicolaus lowered their target price on HLS Therapeutics from C$3.75 to C$3.25 in a research note on Tuesday.August 13, 2024 | marketbeat.comFDA gives thumbs down to MDMA for now, demanding further researchAugust 13, 2024 | msn.comHLS Therapeutics Inc. to Post Q3 2024 Earnings of ($0.21) Per Share, Raymond James Forecasts (TSE:HLS)HLS Therapeutics Inc. (TSE:HLS - Free Report) - Analysts at Raymond James upped their Q3 2024 earnings per share (EPS) estimates for HLS Therapeutics in a research report issued on Thursday, August 8th. Raymond James analyst R. Sarugaser now anticipates that the company will post earnings per shaAugust 12, 2024 | marketbeat.comHLS Therapeutics Announces Q2 2024 Financial ResultsAugust 8, 2024 | finance.yahoo.comHLS Therapeutics (TSE:HLS) Hits New 12-Month Low at $3.02HLS Therapeutics (TSE:HLS) Sets New 12-Month Low at $3.02August 2, 2024 | marketbeat.comAmarin Corporation plc (NASDAQ:AMRN) Q2 2024 Earnings Call TranscriptAugust 1, 2024 | msn.comHLS Therapeutics (HLS) Scheduled to Post Quarterly Earnings on ThursdayHLS Therapeutics (TSE:HLS) will be releasing earnings before the market opens on Thursday, August 8, Zacks reports.August 1, 2024 | marketbeat.comAmarin Plc (AMRN) Q2 2024 Earnings Call TranscriptJuly 31, 2024 | msn.comHLS Announces Reimbursement for Vascepa® under Alberta's Provincial Drug PlanJuly 29, 2024 | finance.yahoo.comFTSE 100 LIVE: European stocks slump after Wall Street suffers worst sell-off in over a yearJuly 25, 2024 | sg.finance.yahoo.comHLS Therapeutics to Host Q2 Fiscal 2024 Financial Results Conference CallJuly 25, 2024 | ca.finance.yahoo.comHLS Therapeutics (TSE:HLS) Reaches New 12-Month Low at $3.07HLS Therapeutics (TSE:HLS) Reaches New 1-Year Low at $3.07July 24, 2024 | marketbeat.comClosing Bell: Hls Therapeutics Inc flat on Wednesday (HLS)July 19, 2024 | theglobeandmail.comHLS Therapeutics (TSE:HLS) Hits New 12-Month Low at $3.25HLS Therapeutics (TSE:HLS) Hits New 52-Week Low at $3.25July 2, 2024 | marketbeat.comHLS Therapeutics (TSE:HLS) Sets New 52-Week Low at $3.26HLS Therapeutics (TSE:HLS) Reaches New 1-Year Low at $3.26June 17, 2024 | marketbeat.comNew Study Published on the Impact of Pharmaceutical Support Programs on Persistence with Clozapine TreatmentMay 28, 2024 | finance.yahoo.comRaymond James Lowers HLS Therapeutics (TSE:HLS) Price Target to C$4.00Raymond James reduced their price objective on shares of HLS Therapeutics from C$5.00 to C$4.00 in a research note on Friday.May 10, 2024 | marketbeat.comHLS Therapeutics Inc HLSMay 9, 2024 | morningstar.comHLS Therapeutics Announces Q1 2024 Financial ResultsMay 9, 2024 | finance.yahoo.comHLS Therapeutics to Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceApril 9, 2024 | finance.yahoo.comNew REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient SubgroupsApril 8, 2024 | finance.yahoo.comHLS Therapeutics (TSE:HLS) PT Lowered to C$5.00 at Raymond JamesRaymond James lowered their price objective on HLS Therapeutics from C$6.50 to C$5.00 in a report on Monday.March 18, 2024 | marketbeat.comEarnings Release: Here's Why Analysts Cut Their HLS Therapeutics Inc. (TSE:HLS) Price Target To CA$6.57March 17, 2024 | finance.yahoo.comStifel Nicolaus Trims HLS Therapeutics (TSE:HLS) Target Price to C$4.15Stifel Nicolaus cut their price objective on HLS Therapeutics from C$4.35 to C$4.15 in a research report on Friday.March 15, 2024 | marketbeat.comHLS Therapeutics Inc. (TSE:HLS) stock most popular amongst retail investors who own 40%, while hedge funds hold 39%March 14, 2024 | finance.yahoo.comHLS Therapeutics Announces Fiscal 2023 Financial ResultsMarch 14, 2024 | finance.yahoo.comHLS Therapeutics earnings: here's what to expectMarch 13, 2024 | markets.businessinsider.comSeveral Insiders Invested In HLS Therapeutics Flagging Positive NewsFebruary 21, 2024 | finance.yahoo.comHLS Therapeutics Inc. (TSE:HLS) Expected to Post FY2023 Earnings of ($0.93) Per ShareHLS Therapeutics Inc. (TSE:HLS - Free Report) - Clarus Securities issued their FY2023 earnings per share (EPS) estimates for shares of HLS Therapeutics in a report issued on Tuesday, February 6th. Clarus Securities analyst G. Ulybyshev expects that the company will post earnings of ($0.93) per shFebruary 9, 2024 | marketbeat.comHLS Therapeutics' (HLS) "Buy" Rating Reiterated at Clarus SecuritiesClarus Securities reaffirmed a "buy" rating on shares of HLS Therapeutics in a research note on Tuesday.February 9, 2024 | marketbeat.comStocks in play: HLS Therapeutics Inc.February 6, 2024 | ca.finance.yahoo.comHLS Announces that Vascepa® is now reimbursed by British Columbia's Provincial Drug PlanFebruary 6, 2024 | finance.yahoo.comPharma breakthroughs: 10 novel drug approvals that made headlines in 2023December 20, 2023 | msn.comHLS Therapeutics CFO Tim Hendrickson to Step DownDecember 18, 2023 | marketwatch.com Get HLS Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HLS and its competitors with MarketBeat's FREE daily newsletter. Email Address 2024 Election Year Stocks: Uncover Hidden Gems! (Ad)In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss. Secure your copy now by clicking this link. HLS Media Mentions By Week HLS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HLS News Sentiment▼-0.350.56▲Average Medical News Sentiment HLS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HLS Articles This Week▼61▲HLS Articles Average Week Get HLS Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HLS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Aurora Cannabis News Today Cipher Pharmaceuticals News Today Organigram News Today Cardiol Therapeutics News Today BioSyent News Today Medexus Pharmaceuticals News Today Decibel Cannabis News Today Charlotte's Web News Today MediPharm Labs News Today Willow Biosciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:HLS) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HLS Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HLS Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HLS Stock Alerts